| |
| |
|
| Insider
Information: |
New Enterprise Associates 14, L.p. |
| Relationship: |
10% Owner |
| City: |
Timonium |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
67,662,725 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$24,993,771 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
67,662,725 |
|
|
| Total
Value |
$24,993,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interleukin Genetics Inc |
ILIU |
10% Owner |
2016-07-29 |
55,418,811 |
|
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-06 |
2,971,517 |
2015-10-05 |
0 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
3,312,877 |
2018-04-23 |
0 |
Premium* |
|
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
0 |
2018-02-13 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
5,959,520 |
2020-04-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRSN |
Mersana Therapeutics, Inc... |
10% Owner |
– – • |
2020-09-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,000,000) |
5,959,520 |
0 |
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
10% Owner |
– – • |
2020-04-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,000,000) |
7,959,520 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2018-04-23 |
4 |
B |
$15.00 |
$1,999,995 |
D/D |
133,333 |
3,312,877 |
2.45 |
- |
|
| SURF |
Surface Oncology, Inc. |
10% Owner |
– – • |
2018-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
3,179,544 |
3,179,544 |
0 |
- |
|
| APPN |
Appian Corp |
10% Owner |
– – • |
2018-02-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,724,202) |
0 |
0 |
- |
|
| APPN |
Appian Corp |
10% Owner |
– – • |
2018-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,724,202 |
2,724,202 |
0 |
- |
|
| ILIU |
Interleukin Genetics Inc |
10% Owner |
– – • |
2016-07-29 |
4 |
B |
$0.10 |
$2,000,000 |
D/D |
20,120,724 |
55,418,811 |
2.45 |
- |
|
| SYBX |
Synlogic Inc |
10% Owner |
– – • |
2015-10-06 |
4 |
B |
$7.00 |
$5,999,994 |
D/D |
857,142 |
2,971,517 |
2.45 |
- |
|
| SYBX |
Synlogic Inc |
10% Owner |
– – • |
2015-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
289,166 |
2,114,375 |
0 |
- |
|
| SYBX |
Synlogic Inc |
10% Owner |
– – • |
2015-10-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,825,209 |
2,082,725 |
0 |
- |
|
| ILIU |
Interleukin Genetics Inc |
10% Owner |
– – • |
2014-12-23 |
4 |
B |
$0.10 |
$1,992,857 |
D/D |
19,868,965 |
35,298,087 |
2.45 |
- |
|
| ILIU |
Interleukin Genetics Inc |
10% Owner |
– – • |
2013-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,429,122 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
